» Articles » PMID: 36874265

A Case Report of Covid-19 in an Autoimmune Pulmonary Alveolar Proteinosis: An Association in Tune with the Times!

Overview
Date 2023 Mar 6
PMID 36874265
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the alveoli accumulation of surfactants proteins and lipids, which diagnosis is confirmed by the presence of GM-CSF antibodies in serum. PAP can be evoked when its characteristic images on chest computed-tomography (CT) are present: bilateral and multifocal ground-glass opacities and crazy-paving appearance. Patients with PAP are at an increased risk of opportunistic infections caused by Nocardia, mycobacteria and fungal pathogens due to impaired processing of pulmonary surfactant. We here report a typical case of newly diagnosed autoimmune PAP, with initial indication to realize a whole-lung lavage. Despite this treatment the patient presented a marked clinical worsening, with increasing need for oxygen and finally the need for mechanical ventilation. The chest CT was controlled and found to be typical of PAP, while the search for opportunistic infections remained negative. Finally, SARS-CoV-2 PCR was performed on bronchoalveolar lavage fluid, and was positive, whereas it had previously been negative twice. Our case report highlights the difficulty of distinguishing SARS-CoV-2 infection in the context of PAP, as the chest CT features are similar. We believe that a SARS-CoV-2 RT-PCR should be systematically realized in case of respiratory deterioration in PAP patients.

Citing Articles

Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.

Meher V, Huntsman R, Green F, Wooff J, Auer R Pathophysiology. 2025; 32(1.

PMID: 39846640 PMC: 11755659. DOI: 10.3390/pathophysiology32010003.


Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study.

Duan C, Zhou W, Zhang M, Cheng C, Xu W, Dai J Orphanet J Rare Dis. 2023; 18(1):353.

PMID: 37951939 PMC: 10638736. DOI: 10.1186/s13023-023-02950-9.

References
1.
Punatar A, Kusne S, Blair J, Seville M, Vikram H . Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect. 2012; 65(2):173-9. DOI: 10.1016/j.jinf.2012.03.020. View

2.
Trapnell B, Nakata K, Bonella F, Campo I, Griese M, Hamilton J . Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019; 5(1):16. DOI: 10.1038/s41572-019-0066-3. View

3.
Michaud G, Reddy C, Ernst A . Whole-lung lavage for pulmonary alveolar proteinosis. Chest. 2009; 136(6):1678-1681. DOI: 10.1378/chest.09-2295. View

4.
Machnicki S, Patel D, Singh A, Talwar A, Mina B, Oks M . The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19: A Review of Literature. Chest. 2021; 160(2):652-670. PMC: 8056836. DOI: 10.1016/j.chest.2021.04.004. View

5.
Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. DOI: 10.1001/jama.2012.5669. View